Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

I’m talking, of course, about public domain and the intricacies of copyright law. A few years ago, a 20-year moratorium on published works entering the public domain in the US ended, and now ...

Each year on January 1, 95-year-old copyrights expire and a multitude of works enter the public domain, allowing them to be freely adapted and interpreted by anyone in the United States.

Where public domain videos might contain copyrighted images like logos, sites like iStock ensure that you won ... Licensing Navigating the Risks of AI‑Generated Images in Stock Photo Libraries Avoid ...

A new year means a new start, and for some pieces of media, it means entering the public domain. In 2024, one of the most famous additions to the public domain was the first iteration of Mickey ...

The title track from the hit play and movie entered the public domain Wednesday alongside a bevy of other songs, characters and literature first published in the mid-1920s. This year, Virginia ...

However, the public domain can also open old art to newer audiences. As noted by the Library of Congress, "It's a Wonderful Life" only became a Christmas classic after Republic Pictures let its ...

Filmmakers working in the ever-expanding genre of public domain horror will soon have even more Mickey Mouse to play with. With every new year comes new works that are set to go into the public ...

Jan. 1 is Public Domain Day, meaning artworks from 1929 (or 1924 in the case of sound recordings) are now free for all creators to use and abuse to their hearts' content. The works of art ...

Even if you're not one for getting dressed up and going out to ring in the new year, there's still something to celebrate on Jan. 1: a new batch of copyrighted works entering the public domain.

Bullish option flow detected in AstraZeneca (AZN) with 5,692 calls trading, 5x expected, and implied vol increasing almost 3 points to 33.14%. Jan-25 65 calls and Dec-24 77.5 calls are the most ...

AstraZeneca in AI Collaboration With Immunai to Inform Cancer Drug Trials (Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model ...